Literature DB >> 12045383

Heart failure, oxidative stress, and ion channel modulation.

Gaurav Choudhary1, Samuel C Dudley.   

Abstract

The balance of reactive oxygen species (ROS) and nitric oxide, the cell redox state, appears to be important in the mechanisms of heart failure. This balance has significant impact on calcium-handling proteins, affecting excitation-contraction coupling. Both ROS and nitric oxide appear to be elevated in heart failure and are accompanied by significant impairments in the number and function of calcium-handling proteins. These proteins contain sulfhydryl groups or disulfide linkages involving cysteine residues, making them susceptible to the action of oxidizing-reducing agents and nitrosylation, thereby altering their properties. Initial increases in nitric oxide may be an adaptive response to myocardial dysfunction, elevated cytokines, and increases in ROS, while a further increase in nitric oxide and overwhelming ROS can be damaging. Abundant nitric oxide and ROS can cause formation of peroxynitrite, a strong oxidant, or nitric oxide can activate alternate pathways aiding the ROS, causing impaired calcium handling contributing to contractile dysfunction. Copyright 2002 CHF, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045383     DOI: 10.1111/j.1527-5299.2002.00716.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  29 in total

1.  Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel.

Authors:  Man Liu; Hong Liu; Samuel C Dudley
Journal:  Circ Res       Date:  2010-08-19       Impact factor: 17.367

Review 2.  Cardiac sodium channel mutations: why so many phenotypes?

Authors:  Man Liu; Kai-Chien Yang; Samuel C Dudley
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

3.  Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A.

Authors:  Kim N Ha; Larry R Masterson; Zhanjia Hou; Raffaello Verardi; Naomi Walsh; Gianluigi Veglia; Seth L Robia
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 4.  Immune modulation in heart failure: past challenges and future hopes.

Authors:  Jose H Flores-Arredondo; Gerardo García-Rivas; Guillermo Torre-Amione
Journal:  Curr Heart Fail Rep       Date:  2011-03

5.  Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban.

Authors:  Neha Abrol; Pieter P de Tombe; Seth L Robia
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

6.  Actovegin reduces the ROS level in blood samples of heart failure patients and diminishes necrosis of SK-N-SH human neuroblastoma cells.

Authors:  E I Astashkin; M G Glezer; M G Vinokurov; N D Egorova; N S Orekhova; A N Novikova; S V Grachev; M M Yurinskaya; K E Sobolev
Journal:  Dokl Biol Sci       Date:  2013-03-12

7.  Correlation between oxidative stress and alteration of intracellular calcium handling in isoproterenol-induced myocardial infarction.

Authors:  Mauricio Díaz-Muñoz; Marco Antonio Alvarez-Pérez; Lucía Yáñez; Susana Vidrio; Lidia Martínez; Gisele Rosas; Mario Yáñez; Sotero Ramírez; Victoria Chagoya de Sánchez
Journal:  Mol Cell Biochem       Date:  2006-07-04       Impact factor: 3.396

Review 8.  Oxidative stress and heart disease: cardiac dysfunction, nutrition, and gene therapy.

Authors:  Elliott J F Cantor; Enrico V Mancini; Rishi Seth; Xing-Hai Yao; Thomas Netticadan
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 9.  Alterations in ryanodine receptors and related proteins in heart failure.

Authors:  Sameer Ather; Jonathan L Respress; Na Li; Xander H T Wehrens
Journal:  Biochim Biophys Acta       Date:  2013-06-14

10.  Oxidative stress markers are associated with persistent atrial fibrillation.

Authors:  Robert B Neuman; Heather L Bloom; Irfan Shukrullah; Lyndsey A Darrow; David Kleinbaum; Dean P Jones; Samuel C Dudley
Journal:  Clin Chem       Date:  2007-06-28       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.